Breast Cancer Research最新文献

筛选
英文 中文
Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production 胰岛素样生长因子1受体的激活通过增加糖酵解和促进生物质生产来促进乳腺肿瘤的发展
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2017-02-07 DOI: 10.1186/s13058-017-0802-0
B. ter Braak, C. Siezen, J. Lee, P. Rao, C. Voorhoeve, E. Ruppin, J. W. van der Laan, B. van de Water
{"title":"Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production","authors":"B. ter Braak, C. Siezen, J. Lee, P. Rao, C. Voorhoeve, E. Ruppin, J. W. van der Laan, B. van de Water","doi":"10.1186/s13058-017-0802-0","DOIUrl":"https://doi.org/10.1186/s13058-017-0802-0","url":null,"abstract":"","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"22 1","pages":""},"PeriodicalIF":7.4,"publicationDate":"2017-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80117499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Non-invasive optical spectroscopic monitoring of breast development during puberty 青春期乳房发育的无创光谱学监测
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2017-02-06 DOI: 10.1186/s13058-017-0805-x
L. Lilge, M. Terry, Jane Walter, Dushanthi Pinnaduwage, G. Glendon, D. Hanna, Mai-Liis Tammemagi, A. Bradbury, S. Buys, M. Daly, E. John, J. Knight, I. Andrulis
{"title":"Non-invasive optical spectroscopic monitoring of breast development during puberty","authors":"L. Lilge, M. Terry, Jane Walter, Dushanthi Pinnaduwage, G. Glendon, D. Hanna, Mai-Liis Tammemagi, A. Bradbury, S. Buys, M. Daly, E. John, J. Knight, I. Andrulis","doi":"10.1186/s13058-017-0805-x","DOIUrl":"https://doi.org/10.1186/s13058-017-0805-x","url":null,"abstract":"","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"20 1","pages":""},"PeriodicalIF":7.4,"publicationDate":"2017-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73434942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells 升高的胶原-i增强了催乳素诱导的雌激素受体阳性乳腺肿瘤细胞的肿瘤进展信号、内渗和转移
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2017-01-19 DOI: 10.1186/s13058-017-0801-1
Craig E. Barcus, K. O'Leary, J. L. Brockman, Debra E. Rugowski, Yuming Liu, N. Garcia, Menggang Yu, P. Keely, K. Eliceiri, L. Schuler
{"title":"Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells","authors":"Craig E. Barcus, K. O'Leary, J. L. Brockman, Debra E. Rugowski, Yuming Liu, N. Garcia, Menggang Yu, P. Keely, K. Eliceiri, L. Schuler","doi":"10.1186/s13058-017-0801-1","DOIUrl":"https://doi.org/10.1186/s13058-017-0801-1","url":null,"abstract":"","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"19 1","pages":""},"PeriodicalIF":7.4,"publicationDate":"2017-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13058-017-0801-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65772551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 93
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression PIK3CA突变在小叶原位癌中很常见,但不是进展的生物标志物
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2017-01-17 DOI: 10.1186/s13058-016-0789-y
Vandna Shah, S. Nowinski, D. Levi, I. Shinomiya, Narda Kebaier Ep Chaabouni, C. Gillett, A. Grigoriadis, T. Graham, R. Roylance, M. Simpson, S. Pinder, E. Sawyer
{"title":"PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression","authors":"Vandna Shah, S. Nowinski, D. Levi, I. Shinomiya, Narda Kebaier Ep Chaabouni, C. Gillett, A. Grigoriadis, T. Graham, R. Roylance, M. Simpson, S. Pinder, E. Sawyer","doi":"10.1186/s13058-016-0789-y","DOIUrl":"https://doi.org/10.1186/s13058-016-0789-y","url":null,"abstract":"","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"49 1","pages":""},"PeriodicalIF":7.4,"publicationDate":"2017-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13058-016-0789-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65772469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells 新型索拉非尼类似物通过SHP-1依赖性STAT3失活诱导人乳腺癌细胞凋亡
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2017-01-11 DOI: 10.1186/s13058-017-0800-2
Chun-Yu Liu, L. Tseng, Jung-Chen Su, Kung-Chi Chang, P. Chu, W. Tai, C. Shiau, Kuen-Feng Chen
{"title":"Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells","authors":"Chun-Yu Liu, L. Tseng, Jung-Chen Su, Kung-Chi Chang, P. Chu, W. Tai, C. Shiau, Kuen-Feng Chen","doi":"10.1186/s13058-017-0800-2","DOIUrl":"https://doi.org/10.1186/s13058-017-0800-2","url":null,"abstract":"","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"18 1","pages":""},"PeriodicalIF":7.4,"publicationDate":"2017-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79842431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is there a difference in reading time when normal and abnormal DBT cases are examined by DBT experienced radiologists? [Poster] 由经验丰富的放射科医生检查正常和异常DBT病例时,阅读时间是否有差异?(海报)
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2017-01-01 DOI: 10.1186/s13058-017-0903-9
L. Dong, Daniella Bernadi, Qiang Tang, A. Gale, Xinyan Liu, Yan Chen
{"title":"Is there a difference in reading time when normal and abnormal DBT cases are examined by DBT experienced radiologists? [Poster]","authors":"L. Dong, Daniella Bernadi, Qiang Tang, A. Gale, Xinyan Liu, Yan Chen","doi":"10.1186/s13058-017-0903-9","DOIUrl":"https://doi.org/10.1186/s13058-017-0903-9","url":null,"abstract":"","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"1 1","pages":""},"PeriodicalIF":7.4,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13058-017-0903-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65772562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems. 对三种乳腺 X 射线摄影系统的成对原始图像和处理过的数字图像,以及成对屏幕胶片图像和数字图像进行乳腺密度评估。
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2016-12-19 DOI: 10.1186/s13058-016-0787-0
Anya Burton, Graham Byrnes, Jennifer Stone, Rulla M Tamimi, John Heine, Celine Vachon, Vahit Ozmen, Ana Pereira, Maria Luisa Garmendia, Christopher Scott, John H Hipwell, Caroline Dickens, Joachim Schüz, Mustafa Erkin Aribal, Kimberly Bertrand, Ava Kwong, Graham G Giles, John Hopper, Beatriz Pérez Gómez, Marina Pollán, Soo-Hwang Teo, Shivaani Mariapun, Nur Aishah Mohd Taib, Martín Lajous, Ruy Lopez-Riduara, Megan Rice, Isabelle Romieu, Anath Arzee Flugelman, Giske Ursin, Samera Qureshi, Huiyan Ma, Eunjung Lee, Reza Sirous, Mehri Sirous, Jong Won Lee, Jisun Kim, Dorria Salem, Rasha Kamal, Mikael Hartman, Hui Miao, Kee-Seng Chia, Chisato Nagata, Sudhir Vinayak, Rose Ndumia, Carla H van Gils, Johanna O P Wanders, Beata Peplonska, Agnieszka Bukowska, Steve Allen, Sarah Vinnicombe, Sue Moss, Anna M Chiarelli, Linda Linton, Gertraud Maskarinec, Martin J Yaffe, Norman F Boyd, Isabel Dos-Santos-Silva, Valerie A McCormack
{"title":"Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems.","authors":"Anya Burton, Graham Byrnes, Jennifer Stone, Rulla M Tamimi, John Heine, Celine Vachon, Vahit Ozmen, Ana Pereira, Maria Luisa Garmendia, Christopher Scott, John H Hipwell, Caroline Dickens, Joachim Schüz, Mustafa Erkin Aribal, Kimberly Bertrand, Ava Kwong, Graham G Giles, John Hopper, Beatriz Pérez Gómez, Marina Pollán, Soo-Hwang Teo, Shivaani Mariapun, Nur Aishah Mohd Taib, Martín Lajous, Ruy Lopez-Riduara, Megan Rice, Isabelle Romieu, Anath Arzee Flugelman, Giske Ursin, Samera Qureshi, Huiyan Ma, Eunjung Lee, Reza Sirous, Mehri Sirous, Jong Won Lee, Jisun Kim, Dorria Salem, Rasha Kamal, Mikael Hartman, Hui Miao, Kee-Seng Chia, Chisato Nagata, Sudhir Vinayak, Rose Ndumia, Carla H van Gils, Johanna O P Wanders, Beata Peplonska, Agnieszka Bukowska, Steve Allen, Sarah Vinnicombe, Sue Moss, Anna M Chiarelli, Linda Linton, Gertraud Maskarinec, Martin J Yaffe, Norman F Boyd, Isabel Dos-Santos-Silva, Valerie A McCormack","doi":"10.1186/s13058-016-0787-0","DOIUrl":"10.1186/s13058-016-0787-0","url":null,"abstract":"<p><strong>Background: </strong>Inter-women and intra-women comparisons of mammographic density (MD) are needed in research, clinical and screening applications; however, MD measurements are influenced by mammography modality (screen film/digital) and digital image format (raw/processed). We aimed to examine differences in MD assessed on these image types.</p><p><strong>Methods: </strong>We obtained 1294 pairs of images saved in both raw and processed formats from Hologic and General Electric (GE) direct digital systems and a Fuji computed radiography (CR) system, and 128 screen-film and processed CR-digital pairs from consecutive screening rounds. Four readers performed Cumulus-based MD measurements (n = 3441), with each image pair read by the same reader. Multi-level models of square-root percent MD were fitted, with a random intercept for woman, to estimate processed-raw MD differences.</p><p><strong>Results: </strong>Breast area did not differ in processed images compared with that in raw images, but the percent MD was higher, due to a larger dense area (median 28.5 and 25.4 cm<sup>2</sup> respectively, mean √dense area difference 0.44 cm (95% CI: 0.36, 0.52)). This difference in √dense area was significant for direct digital systems (Hologic 0.50 cm (95% CI: 0.39, 0.61), GE 0.56 cm (95% CI: 0.42, 0.69)) but not for Fuji CR (0.06 cm (95% CI: -0.10, 0.23)). Additionally, within each system, reader-specific differences varied in magnitude and direction (p < 0.001). Conversion equations revealed differences converged to zero with increasing dense area. MD differences between screen-film and processed digital on the subsequent screening round were consistent with expected time-related MD declines.</p><p><strong>Conclusions: </strong>MD was slightly higher when measured on processed than on raw direct digital mammograms. Comparisons of MD on these image formats should ideally control for this non-constant and reader-specific difference.</p>","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"18 1","pages":"130"},"PeriodicalIF":7.4,"publicationDate":"2016-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65772865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts. 普萘洛尔与乳腺癌存活率:欧洲乳腺癌队列的汇总分析。
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2016-12-01 DOI: 10.1186/s13058-016-0782-5
Chris R Cardwell, Anton Pottegård, Evelien Vaes, Hans Garmo, Liam J Murray, Chris Brown, Pauline A J Vissers, Michael O'Rorke, Kala Visvanathan, Deirdre Cronin-Fenton, Harlinde De Schutter, Mats Lambe, Des G Powe, Myrthe P P van Herk-Sukel, Anna Gavin, Søren Friis, Linda Sharp, Kathleen Bennett
{"title":"Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.","authors":"Chris R Cardwell, Anton Pottegård, Evelien Vaes, Hans Garmo, Liam J Murray, Chris Brown, Pauline A J Vissers, Michael O'Rorke, Kala Visvanathan, Deirdre Cronin-Fenton, Harlinde De Schutter, Mats Lambe, Des G Powe, Myrthe P P van Herk-Sukel, Anna Gavin, Søren Friis, Linda Sharp, Kathleen Bennett","doi":"10.1186/s13058-016-0782-5","DOIUrl":"10.1186/s13058-016-0782-5","url":null,"abstract":"<p><strong>Background: </strong>Preclinical studies have demonstrated that propranolol inhibits several pathways involved in breast cancer progression and metastasis. We investigated whether breast cancer patients who used propranolol, or other non-selective beta-blockers, had reduced breast cancer-specific or all-cause mortality in eight European cohorts.</p><p><strong>Methods: </strong>Incident breast cancer patients were identified from eight cancer registries and compiled through the European Cancer Pharmacoepidemiology Network. Propranolol and non-selective beta-blocker use was ascertained for each patient. Breast cancer-specific and all-cause mortality were available for five and eight cohorts, respectively. Cox regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CIs) for cancer-specific and all-cause mortality by propranolol and non-selective beta-blocker use. HRs were pooled across cohorts using meta-analysis techniques. Dose-response analyses by number of prescriptions were also performed. Analyses were repeated investigating propranolol use before cancer diagnosis.</p><p><strong>Results: </strong>The combined study population included 55,252 and 133,251 breast cancer patients in the analysis of breast cancer-specific and all-cause mortality respectively. Overall, there was no association between propranolol use after diagnosis of breast cancer and breast cancer-specific or all-cause mortality (fully adjusted HR = 0.94, 95% CI, 0.77, 1.16 and HR = 1.09, 95% CI, 0.93, 1.28, respectively). There was little evidence of a dose-response relationship. There was also no association between propranolol use before breast cancer diagnosis and breast cancer-specific or all-cause mortality (fully adjusted HR = 1.03, 95% CI, 0.86, 1.22 and HR = 1.02, 95% CI, 0.94, 1.10, respectively). Similar null associations were observed for non-selective beta-blockers.</p><p><strong>Conclusions: </strong>In this large pooled analysis of breast cancer patients, use of propranolol or non-selective beta-blockers was not associated with improved survival.</p>","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"18 1","pages":"119"},"PeriodicalIF":7.4,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133766/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65772812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer 基于循环无细胞dna的表观遗传学检测可检测早期乳腺癌
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2016-12-01 DOI: 10.1186/s13058-016-0788-z
N. Uehiro, F. Sato, F. Pu, Sunao Tanaka, M. Kawashima, K. Kawaguchi, M. Sugimoto, S. Saji, M. Toi
{"title":"Circulating cell-free DNA-based epigenetic assay can detect early breast cancer","authors":"N. Uehiro, F. Sato, F. Pu, Sunao Tanaka, M. Kawashima, K. Kawaguchi, M. Sugimoto, S. Saji, M. Toi","doi":"10.1186/s13058-016-0788-z","DOIUrl":"https://doi.org/10.1186/s13058-016-0788-z","url":null,"abstract":"","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"18 1","pages":""},"PeriodicalIF":7.4,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13058-016-0788-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65772392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 91
The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis 葡萄糖转运蛋白GLUT1是erbb2诱导的乳腺肿瘤发生所必需的
IF 7.4 1区 医学
Breast Cancer Research Pub Date : 2016-12-01 DOI: 10.1186/s13058-016-0795-0
E. Wellberg, Stevi J Johnson, Jessica Finlay-Schultz, Andrew S. Lewis, Kristina L. Terrell, C. Sartorius, E. Abel, W. Muller, S. Anderson
{"title":"The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis","authors":"E. Wellberg, Stevi J Johnson, Jessica Finlay-Schultz, Andrew S. Lewis, Kristina L. Terrell, C. Sartorius, E. Abel, W. Muller, S. Anderson","doi":"10.1186/s13058-016-0795-0","DOIUrl":"https://doi.org/10.1186/s13058-016-0795-0","url":null,"abstract":"","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"18 1","pages":""},"PeriodicalIF":7.4,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13058-016-0795-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65772542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 48
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信